108 related articles for article (PubMed ID: 38776506)
21. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
[TBL] [Abstract][Full Text] [Related]
22. Prospective study evaluating oncological safety of axillary reverse mapping.
Schunemann E; Dória MT; Silvestre JB; Gasperin P; Cavalcanti TC; Budel VM
Ann Surg Oncol; 2014 Jul; 21(7):2197-202. PubMed ID: 24599413
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
24. Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.
Welsh JL; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2881-2888. PubMed ID: 28766197
[TBL] [Abstract][Full Text] [Related]
25. Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750).
Skarping I; Ellbrant J; Dihge L; Ohlsson M; Huss L; Bendahl PO; Rydén L
BMC Cancer; 2024 Jan; 24(1):86. PubMed ID: 38229058
[TBL] [Abstract][Full Text] [Related]
26. Axillary reverse mapping in breast cancer: An overview.
Abbas Y; Hamdy O
Breast Dis; 2023; 42(1):137-146. PubMed ID: 37154174
[TBL] [Abstract][Full Text] [Related]
27. Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery.
Drapalik LM; Miller ME; Rock L; Li P; Simpson A; Shenk R; Amin AL
Surgery; 2024 Mar; 175(3):579-586. PubMed ID: 37852835
[TBL] [Abstract][Full Text] [Related]
28. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
30. [Comparative analysis of the correlation between axillary treatment and upper limb lymphedema].
Lin Y; Xu Y; Zhang XH; Wang CJ; Sun Q
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):713-716. PubMed ID: 31474063
[TBL] [Abstract][Full Text] [Related]
31. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
33. Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center.
Garcia-Etienne CA; Ferrari A; Della Valle A; Lucioni M; Ferraris E; Di Giulio G; Squillace L; Bonzano E; Lasagna A; Rizzo G; Tancredi R; Scotti Foglieni A; Dionigi F; Grasso M; Arbustini E; Cavenaghi G; Pedrazzoli P; Filippi AR; Dionigi P; Sgarella A
Eur J Surg Oncol; 2020 Jan; 46(1):15-23. PubMed ID: 31445768
[TBL] [Abstract][Full Text] [Related]
34. Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.
Nakamura R; Yamamoto N; Miyaki T; Itami M; Shina N; Ohtsuka M
Breast Cancer; 2018 Jan; 25(1):86-93. PubMed ID: 28735457
[TBL] [Abstract][Full Text] [Related]
35. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
Trials; 2013 Apr; 14():111. PubMed ID: 23782712
[TBL] [Abstract][Full Text] [Related]
36. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node biopsy in breast cancer has a greater node positivity rate than axillary node sample: results from a retrospective analysis.
Macaskill EJ; Dewar S; Purdie CA; Brauer K; Baker L; Brown DC
Eur J Surg Oncol; 2012 Aug; 38(8):662-9. PubMed ID: 22592099
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
40. INTRA OPERATIVE FROZEN EXAMINATION OF SENTINEL LYMPH NODE IN BREAST CANCER.
Vohra LM; Gulzar R; Saleem O
J Ayub Med Coll Abbottabad; 2015; 27(1):40-4. PubMed ID: 26182734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]